The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the expiry in key markets has introduced substantial uncertainty . Investors are now facing the consequences of generic competition